Clinical Trials Directory

Trials / Unknown

UnknownNCT03834246

Smoke Inhalation Injury in Patients Admitted to Intensive Care

Prognostic Factors for Smoke Inhalation Injury in Patients Admitted to Intensive Care

Status
Unknown
Phase
Study type
Observational
Enrollment
700 (estimated)
Sponsor
Centre d'Investigation Clinique et Technologique 805 · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Many Studies have shown that the smoke-inhalation injury is responsible for a high mortality mainly related to the systemic effects of carbon monoxide and cyanide. Respiratory lesions induced by smoke inhalation, is one of predictive factors of mortality. The aim of the study is to identify the clinical and epidemiological characteristics of smoke-inhalation injury and to identify prognostic factors among these patients .

Detailed description

The study is a monocentric, retrospective, descriptive and analytical study , betwen december 1997 and september 2018 in intensive care unit of university of hospital. All patients aged over 18 year and who had received a diagnosis of smoke- inhalation injury and were admitted to the ICU of Medical University Hospital , a referral center in Paris providing HBO therapy , were potentially eligible for inclusion in this investigation. Criteria used for recommending HBO therapy to a patient with transient or prolonged unconsciousness, abnormal neurologic findings on physical examination. Data were analyzed to identify independent factors that may influence mortality.

Conditions

Timeline

Start date
2018-10-16
Primary completion
2019-12-31
Completion
2020-05-31
First posted
2019-02-07
Last updated
2019-02-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03834246. Inclusion in this directory is not an endorsement.